These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 11145939)

  • 1. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.
    Tsimikas S; Palinski W; Witztum JL
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):95-100. PubMed ID: 11145939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression.
    Tsimikas S; Shortal BP; Witztum JL; Palinski W
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):689-97. PubMed ID: 10712392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis.
    Palinski W; Tangirala RK; Miller E; Young SG; Witztum JL
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1569-76. PubMed ID: 7583529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization.
    Torzewski M; Shaw PX; Han KR; Shortal B; Lackner KJ; Witztum JL; Palinski W; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2307-12. PubMed ID: 15528482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.
    Shaw PX; Hörkkö S; Tsimikas S; Chang MK; Palinski W; Silverman GJ; Chen PP; Witztum JL
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1333-9. PubMed ID: 11498462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
    Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
    Freigang S; Hörkkö S; Miller E; Witztum JL; Palinski W
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1972-82. PubMed ID: 9848892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.
    Palinski W; Miller E; Witztum JL
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):821-5. PubMed ID: 7846059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies.
    Hulthe J
    Clin Chim Acta; 2004 Oct; 348(1-2):1-8. PubMed ID: 15369729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in immune responses to oxidized LDL epitopes during aging in hypercholesterolemic apoE(-/-) mice.
    Dimayuga PC; Zhao X; Yano J; Chyu KY
    Am J Physiol Regul Integr Comp Physiol; 2006 Dec; 291(6):R1644-50. PubMed ID: 16825416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.
    Binder CJ; Hörkkö S; Dewan A; Chang MK; Kieu EP; Goodyear CS; Shaw PX; Palinski W; Witztum JL; Silverman GJ
    Nat Med; 2003 Jun; 9(6):736-43. PubMed ID: 12740573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
    Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
    J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
    Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
    J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
    Lee TS; Shiao MS; Pan CC; Chau LY
    Circulation; 1999 Mar; 99(9):1222-9. PubMed ID: 10069791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
    Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
    Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice.
    Smook ML; van Leeuwen M; Heeringa P; Damoiseaux JG; Theunissen R; Daemen MJ; Lutgens E; Tervaert JW
    Clin Exp Immunol; 2008 Nov; 154(2):264-9. PubMed ID: 18778362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized fatty acids promote atherosclerosis only in the presence of dietary cholesterol in low-density lipoprotein receptor knockout mice.
    Khan-Merchant N; Penumetcha M; Meilhac O; Parthasarathy S
    J Nutr; 2002 Nov; 132(11):3256-62. PubMed ID: 12421837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.
    Uusitupa MI; Niskanen L; Luoma J; Vilja P; Mercuri M; Rauramaa R; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1236-42. PubMed ID: 8857919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.